JP2010531659A5 - - Google Patents

Download PDF

Info

Publication number
JP2010531659A5
JP2010531659A5 JP2010514108A JP2010514108A JP2010531659A5 JP 2010531659 A5 JP2010531659 A5 JP 2010531659A5 JP 2010514108 A JP2010514108 A JP 2010514108A JP 2010514108 A JP2010514108 A JP 2010514108A JP 2010531659 A5 JP2010531659 A5 JP 2010531659A5
Authority
JP
Japan
Prior art keywords
protein
modified
composition according
reducing agent
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010514108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010531659A (ja
Filing date
Publication date
Priority claimed from GBGB0712685.7A external-priority patent/GB0712685D0/en
Application filed filed Critical
Publication of JP2010531659A publication Critical patent/JP2010531659A/ja
Publication of JP2010531659A5 publication Critical patent/JP2010531659A5/ja
Pending legal-status Critical Current

Links

JP2010514108A 2007-06-29 2008-06-26 変化した電子伝達経路を有する改変グロビンタンパク質 Pending JP2010531659A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0712685.7A GB0712685D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins (2)
PCT/GB2008/002199 WO2009004309A1 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway

Publications (2)

Publication Number Publication Date
JP2010531659A JP2010531659A (ja) 2010-09-30
JP2010531659A5 true JP2010531659A5 (https=) 2011-08-04

Family

ID=38420974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010514108A Pending JP2010531659A (ja) 2007-06-29 2008-06-26 変化した電子伝達経路を有する改変グロビンタンパク質

Country Status (9)

Country Link
US (1) US8609814B2 (https=)
EP (1) EP2170948B1 (https=)
JP (1) JP2010531659A (https=)
CN (1) CN101711255A (https=)
AU (1) AU2008272721B2 (https=)
BR (1) BRPI0812403B8 (https=)
CA (1) CA2690370A1 (https=)
GB (1) GB0712685D0 (https=)
WO (1) WO2009004309A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6273261B2 (ja) 2012-04-30 2018-01-31 ダウ アグロサイエンシィズ エルエルシー 有害生物防除剤組成物送達ビヒクル
GB201704006D0 (en) * 2017-03-13 2017-04-26 Univ Essex Modified globin proteins
US11504417B2 (en) 2017-07-18 2022-11-22 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
GB201721503D0 (en) * 2017-12-20 2018-01-31 Univ Essex Modified globin proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5884323A (en) * 1995-10-13 1999-03-16 3Com Corporation Extendible method and apparatus for synchronizing files on two different computer systems
WO1997015591A1 (en) * 1995-10-23 1997-05-01 Rice University Hemoglobin mutants that reduce heme loss
GB0712683D0 (en) 2007-06-29 2007-08-08 Wivenhoe Technology Ltd Improvements relating to oxygen-carrying proteins(1)

Similar Documents

Publication Publication Date Title
Kang et al. Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria
JP2008508859A5 (https=)
JP2005527470A5 (https=)
EA035372B1 (ru) Флагеллиновые композиции и их применение
WO2006088473A3 (en) Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents
AU2003273967A1 (en) Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
WO2006116731A3 (en) Personal care compositions comprising a dipeptide
MXPA05005330A (es) Composiciones y formulaciones de gastrina, y metodos de uso y preparacion.
Simons et al. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers
JP2005537234A5 (https=)
JP2004536077A5 (https=)
JP2010531659A5 (https=)
PT3108895T (pt) Tratamento de doenças de armazenanto de glicogénio tipo ii
WO2008064299A3 (en) Methods of reducing porcine circovirus-associated disease outbreaks
WO2006117240A3 (en) Novel method for preventing or treating m tuberculosis infection
TWI812580B (zh) 檸檬酸鐵用於治療缺鐵性貧血之用途
JP2013510169A5 (https=)
JPS62246520A (ja) 白内障の予防及び逆転方法及び眼の組成物
US20220218834A1 (en) Apohemoglobin-haptoglobin complexes and methods of using thereof
US20200308534A1 (en) Recombinant uricase enzyme
MA27699A1 (fr) Vaccin contre vhc
JPWO2021116462A5 (https=)
JP2009510165A5 (https=)
WO2005051902A3 (en) Modified mscl protein channel
WO2007149686A3 (en) Stabilized proteins